Access cutting-edge small cell lung cancer treatment through this clinical trial at a research site in Fort Myers. Study-provided care at no cost to qualified participants.
Access small cell lung cancer specialists in Fort Myers at no cost
This study follows strict safety protocols and ethical guidelines
All study-related small cell lung cancer treatment provided free
The Study is a Phase 3, randomized, three-arm, double-blind, placebo-controlled, multi-regional clinical research study to evaluate the safety and efficacy use of toripalimab alone or in combination with tifcemalimab as consolidation therapy in patients with limited-stage small cell lung cancer without disease progression following chemoradiotherapy. Tifcemalimab is a monoclonal antibody against B and T lymphocyte attenuator (BTLA). Toripalimab is a monoclonal antibody against programmed death
Sponsor: Shanghai Junshi Bioscience Co., Ltd.
Check if you qualify for this small cell lung cancer clinical trial in Fort Myers, FL
If you're searching for small cell lung cancer treatment options in Fort Myers, FL, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Fort Myers research site is actively enrolling participants for this clinical trial. You'll receive care from experienced small cell lung cancer specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.